The Whistleblower’s Case
Waters Kraus Paul & Siegel’s client Mychal Wilson accused the pharmaceutical giant of using illicit bribes, expensive vacations, and sumptuous dinners to gain illegal access to patient medical records and coerce doctors to prescribe the company’s high-priced meds. The resulting suits not only led to state and federal settlements worth hundreds of millions of dollars, but it also led to a California Department of Insurance lawsuit with an additional settlement.
Catch up on our coverage of the case with the past news stories below, then tune in to watch the journey of our client in fighting corporate fraud on the series premiere of Whistleblower, July 13 at 8 p.m. EST on CBS. Missed the episode? Catch up here.
Whistleblower to Receive Multimillion-Dollar Settlement in Medicaid Prescription Drug Fraud Case
A former sales rep for Bristol-Myers Squibb Co. who blew the whistle about the company’s fraudulent business practices will receive a multimillion-dollar settlement for his role in bringing the allegations to light.
Whistleblower Claims Lead to Groundbreaking $30M Settlement for CDI
Whistleblower qui tam lawsuit claiming drug marketing fraud results in $30 million settlement agreement – a first of its kind – between Bristol-Myers Squibb and the California Department of Insurance.
About CBS New Series Whistleblower
Whistleblower takes a thrilling look into the real-life David vs. Goliath stories of heroic people who put everything on the line in order to expose illegal and often dangerous wrongdoing when major corporations rip off U.S. taxpayers. Hosted by attorney Alex Ferrer, a former judge and police officer, each hour introduces cases in which ordinary people step up to do the extraordinary by risking their careers, their families and even their lives to ensure others are not harmed or killed by unchecked, unethical corporate greed. More about the series.
